WBR0393

Revision as of 06:48, 21 November 2013 by Rim Halaby (talk | contribs) (Created page with "{{WBRQuestion |QuestionAuthor={{Rim}} |ExamType=USMLE Step 1 |MainCategory=Pharmacology |SubCategory=Neurology |MainCategory=Pharmacology |SubCategory=Neurology |MainCategory=...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
 
Author [[PageAuthor::Rim Halaby, M.D. [1]]]
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Pharmacology
Sub Category SubCategory::Neurology
Prompt [[Prompt::During a major abdominal surgery, a patient receives an injection of pancuronium to facilitate access to the surgical site by paralyzing his abdominal muscles. Several minutes after the injection is administered, the patient's heart rate and blood pressure increase to 135 bpm and 182/99 mmHg. His core temperature begins to increase steadily reaching 41.2 C. Troubled by the unstable vitals, the anesthesiologist administers a second intravenous agent to counteract the effects of the muscle relaxant. The patient's vitals stabilize soon after the second injection and he begins to defervesce.]]
Answer A AnswerA::Succinylcholine
Answer A Explanation AnswerAExp::
Answer B AnswerB::Dantrolene
Answer B Explanation AnswerBExp::
Answer C AnswerC::Etomidate
Answer C Explanation AnswerCExp::
Answer D AnswerD::Physostigmine
Answer D Explanation AnswerDExp::
Answer E AnswerE::Pralidoxime
Answer E Explanation AnswerEExp::
Right Answer RightAnswer::B
Explanation [[Explanation::

Educational Objective:
References: ]]

Approved Approved::No
Keyword WBRKeyword::Dantrolene, WBRKeyword::Pancuronium, WBRKeyword::Malignant hyperthermia
Linked Question Linked::
Order in Linked Questions LinkedOrder::